[A12-20] Apixaban - Benefit assessment according to § 35a Social Code Book V (dossier assessment)
Last updated 02.04.2013
Project no.:
A12-20
Commission:
Commission awarded on 18.12.2012 by the Federal Joint Committee (G-BA).
Report type:
Dossier assessment
Status:
Commission completed
Department/Division:
Drug Assessment
Topic:
Prevention and screening, Head and nerves
Note:
After completion of the assessment by IQWiG the Federal Joint Committee (G-BA) conducts a commenting procedure. This may provide supplementary information and as a result lead to a modified benefit assessment. Further information and the decision on the early benefit assessment can be found on the relevant page of the G-BA website.
Accompanying information| Project no. | Title | Status |
|---|---|---|
| A14-28 | Apixaban (extension of approval) - Benefit assessment according to §35a Social Code Book V (dossier assessment) | Commission completed |
| A11-30 | Apixaban - Benefit assessment according to § 35a Social Code Book V (dossier assessment) | Commission completed |